Novartis AG (NVS)

Growth

Revenue 5Y2.55%
Revenue 3Y0.93%
EPS 5Y30.56%
EPS 3Y25.34%
Dividend 5Y3.82%
Dividend 3Y3.03%

Capital Efficiency

ROIC10.86%
ROE34.47%
ROA18.40%
ROTA25.18%

Capital Structure

Market Cap182.50B
EV202.31B
Cash8.73B
Current Ratio1.31
Debt/Equity0.49
Net Debt/EBITDA0.64
Show More

Segments & KPIs

Select a metric from the list below to chart it

Dec '12
Dec '14
Dec '16
Dec '18
Dec '20
Dec '22
Segments & KPIs
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Innovative Medicines Revenue
Innovative Medicines Revenue % Chg.
Sandoz Revenue
Sandoz Revenue % Chg.
Innovative Medicines Gross Profit
Innovative Medicines Gross Profit % Chg.
Sandoz Gross Profit
Sandoz Gross Profit % Chg.
Corporate Gross Profit
Corporate Gross Profit % Chg.
Innovative Medicines Operating Profit
Innovative Medicines Operating Profit % Chg.
Sandoz Operating Profit
Sandoz Operating Profit % Chg.
Corporate Operating Profit
Corporate Operating Profit % Chg.